Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development-Reference-Cited by-同舟云学术

Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development

Published:2015-11 Issue:22 Volume:25 Page:5172-5177
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Murphy-Benenato Kerry E.,Gingipalli Lakshmaiah,Boriack-Sjodin P. Ann,Martinez-Botella Gabriel,Carcanague Dan,Eyermann Charles J.,Gowravaram Madhu,Harang Jenna,Hale Michael R.,Ioannidis Georgine,Jahic Harris,Johnstone Michele,Kutschke Amy,Laganas Valerie A.,Loch James T.,Miller Matthew D.,Oguto Herbert,Patel Sahil Joe

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference27 articles.

1. From fragments to leads: novel bacterial NAD + -dependent DNA ligase inhibitors

2. Specific Inhibition of the Eubacterial DNA Ligase by Arylamino Compounds

3. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: Novel structure-function relationship and identification of a specific inhibitor

4. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in the chemistry of Negishi coupling: a review;Chemical Papers;2024-03-10

2. Incorporation of a cyclobutyl substituent in molecules by transition metal-catalyzed cross-coupling reactions;Organic & Biomolecular Chemistry;2022

3. Bicyclic 6-6 Systems: Three Heteroatoms 1:2;Comprehensive Heterocyclic Chemistry IV;2022

4. The search for novel treatment strategies for Streptococcus pneumoniae infections;FEMS Microbiology Reviews;2021-01-05

5. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA);European Journal of Medicinal Chemistry;2020-11